Literatur
-
01
Karpanu E .
et al .
JACC 2005; Abstract 405A.
-
02
Makino H .
et al .
Diab Care.
2007;
30 (6)
1577-1578
-
03
Barnett AH .
et al .
N Engl J Med.
2004;
351 (19)
1952-1961
01 INcideNt to OVert: Angiotensin II receptor blocker, Telmisartan, Investigation On type II diabetic Nephropathy
02 Diabetics Exposed to Telmisartan And Enalapril
03 Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial
